Viewing nowArotor Tablet (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

MFDS item code 201310964 · Approved 2013.12.31 · Insurance code 648602590
Improvement of hyperlipidemia; prevention of cardiovascular diseases (such as myocardial infarction and stroke)
This medication is used to reduce the risk of cardiovascular diseases and to treat hyperlipidemia. It particularly helps decrease the risk of myocardial infarction, stroke, and complications related to vascular surgery in adults with risk factors for coronary heart disease or those with type 2 diabetes. In patients already with heart disease, it assists in reducing the risk of myocardial infarction, stroke, and hospitalization due to congestive heart failure. Additionally, it decreases total cholesterol, LDL cholesterol, apo-B protein, and triglyceride levels and increases HDL cholesterol levels, aiding dietary therapy in patients with primary and mixed hyperlipidemia. It is also used in pediatric patients aged 10 to 17 with heterozygous familial hypercholesterolemia to lower cardiovascular disease risk. Overall, this drug helps improve cardiovascular health and manage hyperlipidemia.
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medication may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medication is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the treatment goal is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medication is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Elderly patients: The efficacy and safety in patients aged 70 years or older are generally similar to those in the adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medication daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medication higher than 20 mg in pediatric patients).
This medication should be discontinued immediately if any unusual muscle symptoms appear, especially muscle pain or weakness, and a significant increase in creatine kinase levels should be closely monitored. This drug should not be administered to patients with certain conditions, such as those with liver disease or muscle diseases, women who are pregnant or breastfeeding, children under 10 years old, and patients on certain medications. Patients with a history of alcohol abuse or liver disease, impaired kidney function, and the elderly should exercise particular caution while using this medication and should be monitored frequently for muscle-related side effects. Generally, this drug is well-tolerated, but rare side effects may include liver dysfunction, myopathy, allergic reactions, gastrointestinal disturbances, headache, dizziness, and skin rashes. Any persistent or worsening symptoms should be reported to a healthcare professional. This medication can interact with other drugs; especially, it should be discussed with a doctor or pharmacist when taken with certain antibiotics, antifungals, antivirals, antidiabetic medicines, and oral contraceptives. Women who are pregnant or may become pregnant must ensure appropriate contraceptive methods during treatment with this drug, and should discontinue it immediately upon confirmation of pregnancy. Additionally, breastfeeding women should not take this medication. The safety and efficacy of this drug in children have not been adequately established, so it should be used with caution in pediatric patients under 18 years of age. Elderly patients are at a higher risk for muscle-related side effects, so they should consult healthcare professionals immediately if any unusual symptoms occur while taking this medication. In case of overdose, as there is no specific antidote, treatment should be symptomatic and the liver function and muscle status should be regularly evaluated. This medication should be stored out of reach of children, kept in the original container, and not transferred to other containers for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, at a temperature between 1°C and 30°C, as this helps maintain the medication's effectiveness.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.